Dianthus Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2025
New
$1.35B
$327,000
0.0% of portfolio
8,970
Q3 2025
Reduced 53.33%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 59.27%
$4.44B
$540,000
0.0% of portfolio
15,820
Q3 2025
Reduced 35.61%
$8.35B
$669,000
0.0% of portfolio
1,090
Q3 2025
Reduced 47.85%
$2.03B
$397,000
0.0% of portfolio
7,479
Q3 2025
Reduced 43.68%
-
$0
0.0% of portfolio
-
Q3 2025
Added 144.16%
$1.38B
$417,000
0.0% of portfolio
27,392
Q3 2025
Reduced 46.54%
$4.04B
$775,000
0.0% of portfolio
10,718
Q3 2025
Reduced 41.96%
$10.5B
$1.24 Million
0.0% of portfolio
15,160
Q3 2025
Reduced 57.67%
$1.37B
$229,000
0.0% of portfolio
4,453
Q3 2025
Reduced 66.53%
$1.07B
$375,000
0.0% of portfolio
12,604
Q3 2025
Reduced 29.01%
$4.14B
$845,000
0.0% of portfolio
5,422
Q3 2025
Reduced 56.35%
$1.71B
$540,000
0.0% of portfolio
45,076
Q3 2024
Reduced 2.9%
$2.09B
$631,000
0.0% of portfolio
40,550
Q3 2025
Reduced 43.88%
$2.33B
$462,000
0.0% of portfolio
28,706
Q3 2025
Reduced 39.51%
$11.2B
$1.96 Million
0.0% of portfolio
17,377
Q3 2025
Reduced 50.03%
$2.6B
$1.24 Million
0.0% of portfolio
50,350
Q3 2025
Added 16.15%
$2.97B
$534,000
0.0% of portfolio
39,200
Q3 2025
Reduced 36.62%
$1.71B
$588,000
0.0% of portfolio
4,944
Q3 2025
Reduced 61.95%
$8.58B
$1.56 Million
0.0% of portfolio
5,353
Q3 2025
Reduced 46.49%
$975M
$254,000
0.0% of portfolio
20,150
Q1 2025
Reduced 93.62%
$534M
$191,000
0.0% of portfolio
9,480
Q3 2025
Reduced 50.18%
$7.44B
$1.1 Million
0.0% of portfolio
4,723
Q3 2025
Reduced 54.53%
$14.5B
$2.64 Million
0.0% of portfolio
24,791
Q3 2025
Reduced 44.9%
-
$0
0.0% of portfolio
-
Q3 2025
New
$3.13B
$726,000
0.0% of portfolio
40,001
Q3 2025
Reduced 31.09%
$7.7B
$1.78 Million
0.0% of portfolio
10,489
Q3 2025
Reduced 45.03%
$7.23B
$1.17 Million
0.0% of portfolio
18,600
Q3 2025
Reduced 48.41%
$2.39B
$1.88 Million
0.0% of portfolio
24,600
Q3 2025
Reduced 47.38%
$940M
$332,000
0.0% of portfolio
16,326
Q3 2025
Reduced 9.68%
$10B
$1.79 Million
0.0% of portfolio
88,710
Q3 2025
Reduced 44.68%
$8.64B
$1.9 Million
0.0% of portfolio
22,496
Q3 2025
Reduced 28.14%
$6.27B
$1.1 Million
0.0% of portfolio
43,656
Q3 2025
Reduced 42.26%
$824M
$149,000
0.0% of portfolio
11,508
Q3 2025
Reduced 83.84%
$842M
$235,000
0.0% of portfolio
16,715
Q3 2025
Reduced 16.9%
$1.07B
$207,000
0.0% of portfolio
4,887
Q3 2025
Reduced 74.79%
$1.18B
$190,000
0.0% of portfolio
4,562
Q3 2025
Reduced 65.21%
$367M
$294,000
0.0% of portfolio
32,385
Q3 2025
Reduced 97.05%
$1.7B
$426,000
0.0% of portfolio
17,123
Q3 2025
Reduced 49.15%
$2.2B
$522,000
0.0% of portfolio
12,750
Q3 2025
Reduced 60.16%
$5.59B
$679,000
0.0% of portfolio
6,015
Q3 2025
Reduced 53.78%
$4.02B
$693,000
0.0% of portfolio
6,026
Q3 2025
Reduced 63.09%
$1.62B
$494,000
0.0% of portfolio
16,284
Q1 2024
Reduced 4.81%
$1.26B
$415,000
0.0% of portfolio
41,685
Q3 2025
Reduced 49.92%
$4.37B
$1.29 Million
0.0% of portfolio
5,693
Q3 2025
Reduced 37.05%
$9.87B
$1.87 Million
0.0% of portfolio
10,819
Q3 2025
Reduced 59.48%
$11.7B
$2.69 Million
0.0% of portfolio
29,080
Q3 2025
Reduced 44.38%
$3.17B
$817,000
0.0% of portfolio
40,111
Q3 2025
Reduced 29.71%
$874M
$589,000
0.0% of portfolio
53,450
Q3 2025
New